RecruitingNCT04510740

Liver Cancer Registry Platform

JADE - Clinical Research Platform on Treatment and Outcome in Patients With Hepatocellular or Cholangiocellular Cancer

Sponsor

iOMEDICO AG

Enrollment

1,000 participants

Start Date

Aug 9, 2020

Study Type

OBSERVATIONAL

Conditions

Cholangiocarcinoma Hepatocellular Carcinoma (HCC)

Summary

The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma (CCC) in Germany.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry and data platform for people with liver cancer — specifically hepatocellular carcinoma (HCC, the most common type of liver cancer) or cholangiocarcinoma (bile duct cancer). It collects clinical data and patient-reported outcomes to improve understanding of liver cancer across its stages. **You may be eligible if...** - You have been confirmed with HCC or cholangiocarcinoma at any stage (early, intermediate, or advanced) - You are 18 or older - You are willing to sign a consent form **You may NOT be eligible if...** - You have not been diagnosed with HCC or cholangiocarcinoma - You are unable or unwilling to provide informed consent within the required timeframe after starting treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPhysician's choice according to patient's needs.

Routine care as per site standard.

Locations(1)

Multiple sites all over germany

Multiple Sites, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04510740

Related Trials

Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study)

NCT072652711 location

Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma

NCT0726017512 locations